APA (7th ed.) Citation

M, V., H, F., A, D., S, R., A, S., RJ, T., . . . JG, C. (2022). Intravenous prostanoids in systemic sclerosis-associated pulmonary arterial hypertension: A single-centre experience. Rheumatology (Oxford, England), 61(3), 1106. https://doi.org/10.1093/rheumatology/keab478

Chicago Style (17th ed.) Citation

M, Vlachou, Fayed H, Dawson A, Reddecliffe S, Stevenson A, Thomson RJ, Schreiber BE, and Coghlan JG. "Intravenous Prostanoids in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Single-centre Experience." Rheumatology (Oxford, England) 61, no. 3 (2022): 1106. https://doi.org/10.1093/rheumatology/keab478.

MLA (9th ed.) Citation

M, Vlachou, et al. "Intravenous Prostanoids in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Single-centre Experience." Rheumatology (Oxford, England), vol. 61, no. 3, 2022, p. 1106, https://doi.org/10.1093/rheumatology/keab478.